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The reproductive hormone, relaxin, inhibits collagen syn-
thesis in vitro by normal human dermal fibrob lasts. In the 
present study, recombinant human relaxin is shown to mod-
ulate collagen accumulation and organization by mesenchy-
mal cells in vivo in two rodent models of fibrosis: 1) fibrotic 
infiltration of polyvinyl alcohol sponge implants in rats, and 
2) capsule formation around implanted osmotic pumps in 
mice. In the sponge, relaxin inhibits collagen accumulation, 
as measured by hydroxyproline content, in a dose-responsive 
manner by up to 25-29% in animals receiving 30 ngjml 
T he fibrous protein, collagen, is the major protein com-ponent of the extracellular compartment of tissues, conferring on the interstitium tensile strength and a framework upon which other matrix elements are or-. ganized. The regulation of expression of collagen, 
then, has important implications in tissue expansion as it occurs 
during growth and tissue remodeling during development and 
wound healing. Many cytokines, such as transforming growth fac-
tor-p [1-4] and platelet-derived growth factor [4], have shown 
potent effects on wound healing in vivo and modulatory effects on 
the expression of collagen in vitro [5,6]. Recently, we have shown 
that the peptide hormone, relaxin, can also decrease the expression 
of interstitial collagens by human dermal fibroblasts in culture [7]. 
In addition, relaxin induces a small increase in the secretion of the 
interstitial collagen-degrading metalloproteinase, collagenase. It 
has been reported that porcine relaxin can decrease collagen syntlle-
sis in explanted human tissues of the reproductive system, such as 
cervical and uterine explants [8], and can also modulate the release 
of connective tissue-degrading enzymes in tissues of the rat uterus, 
cervix, and granulosum [9]. These results are consistent with re-
laxin's postulated role ill vivo in initiating the structural remodeling 
of the cervix and interpubic ligament in preparation for parturition 
[10]. Indeed, when exogenous relaxin is administered to rodents, it 
causes an expansion of pubic ligaments, a change that is accompa-
nied ultrastructurally by a decrease in the density and integrity of 
collagen bundles in a li gament [11]. 
In the present study, we evaluated the possibility that relaxin 
administered in vivo can decrease collagen accumulation by mesen-
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relaxin, a finding supported by a decrease in collagen-specific 
trichrome staining in sections of sponges from relaxin-
treated animals. In mice, the capsules surrounding relaxin-
containing pumps are thinner and less dense than are capsules 
from control pumps. Ultrastructurally, control capsules are 
composed of densely packed parallel arrays of collagen fibrils, 
whereas fibrils more frequently are not packed in parallel 
arrays and are less abundant in treated capsules. Key words: 
scleroderma/connective tissue. ] Invest Dermatol 101 :280-
285, 1993 
chymal cells outside of the reproductive system in two rodent 
models of fibrosis: 1) fibrous capsule formation around subcutane-
ously implanted osmotic pumps [12], and 2) fibrotic infiltration of 
polyvinyl alcohol sponge implants in rats [13]. We have found that 
in a dose-dependent fashion, relaxin can decrease active collagen 
accumulation in vivo and that this decrease is reflected by histologic 
and ultrastructural differences in patterns of interstitial collagen 
accumulation. These results suggest that relaxin may have potential 
utility as a collagen-modulating agent in diseases such as sclero-
derma. 
MATERIALS AND METHODS 
Animals Female CAF, (BALB/c X AJ) mice were obtained from the 
Jackson Laboratory (Bar Harbor, ME) and were 8 to 14 weeks old at the start 
of the experiments. Female Sprague-Dawley rats, 200 to 250 g, were pur-
chased from Charles River Laboratory (Wilmington, MA). All animal stud-
ies were performed in research facilities fully accredited by the American 
Association for the Accreditation of Laboratory Animal Care. 
Reagents Recombinant human relaxin was expressed and purified at 
Genentech (S. San Francisco, CAl [14] . Human re laxin bas been shown 
previously to be bioactive in rats [15] and mice [16]. Recombinant human 
interferon (IFN)-y (specific activity, 2.65 X 107U/mg) was also cloned, 
expressed, and purified at Genentech [17]. 
Pump Implantation in Mice Osmotic pumps (Model 2002, Alza Corp., 
CAl were loaded with diluent phosphate-buffered saline (PBS) alone or 
23.2 J.lg relaxin/kg body weight (0.76 J.lg relaxin/mouse), a quantity calcu-
lated to result in the delivery of a sustained serum concentration of 1 ng/ml 
relaxin for 14 d. Pregnant rodents have demonstrated circulating relaxin 
levels in the range of 50 to 100 ng/ml [1 8] , whereas serum levels in pregnant 
women range from 0.2 to 1.2 ng/ml [19]. Pumps were also loaded to deliver 
IFN-y, which was used as a positive control, at a rate of 2 X 10'U / h, a dose 
that has previously been shown to cause significant reduction in capsule 
formation [1 2]. Each pump measured 3.0 X 0.7 cm. To implant the pnmp, a 
small full-thickness cut was made on the dorsal surface of 12 ether-anesthe. 
tized mice. A subcutaneous pouch was made by blunt dissection, the pump 
inserted with the exit port facing cranially, and wounds closed with two 
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Figure 1. Section of capsule harvested from pump containing PBS (A) or 
relaxin (B). Capsules were harvested, fixed, cross sectioned, and stained with 
hematoxylin and Masson's trichrome, as described in Materials alld Methods. 
Capsules from relaxin-treated animals were thinner and contained fewer 
cells than those from control animals. Interstitial spaces in both capsules 
stained with trichrome, which indicates collagenous material. Bar, 100 /lm. 
autoclips. At 14 d, the animals were anesthetized, bled for determination of 
circulating relaxin levels [20], and kIl led. Pumps were removed ell bloc With 
fibrous capsule intact. Capsules were carefully dissected and samples were 
formalin-fixed for histologic examination or fixed in Karnovsky II solution 
for electron microscopy. 
Polyvinyl Alcohol Sponge Impl~ntati.on in Rats Nineteen ra~ were 
anesthetized With an mtramuscular lIlJectlOn of a mixture of ketamme hy-
drochloride, xylazine hydrochloride, and acetylpromazine maleate. Four 
previously weighed sterilized polyvinyl alcohol sponge disks (Unipoint In-
dustries, Inc., High Point, NC) were implanted subcutaneously beneath the 
ventral abdominal panniculus carnosus muscle through a small skin incision. 
All sponges were 3 mm thick X 12 mm in diameter. Half of them were 
disk-shaped, as previously described [13] . The other half were centrally 
perforated such that they. were ri~lgs rathe~ than disks. This design was used 
to provide a central wre 1I1to whKh new tissue mgrowth could occu~. Two 
of each design were unplanted m each rat. Osmotic pumps, used 111 tillS 
model simply to deliver re laxin, were loaded with diluent alone or with 
0.94, 5.84, and 11.53 /lg/kg relaxin, calculated to deliver sustained serum 
concentrations of 5, 15, and 30 ng/ml relaxin. One or two pumps were 
implanted in a dorsal subcutaneous pouch and there were 4 to 5 rats in each 
treatment group. Skin incisions were closed with 4-0 stainless steel suture. At 
14 d, the animals were anesthetized and blood was drawn for assay of circu-
lating relaxin levels. The animals were killed and the sponges were removed. 
Two of the sponges, one of each design, were hemisected and fixed for 
histologic and ultrastructural examination, as described above. The other 
two sponges were weighed hydrated (Sartorius Research, West Germany), 
and then weighed again following dehydration in acetone for 24 h. The 
dried sponges were then assayed for hydroxyproline content. 
Hydroxyproline Analysis Sponges were hydrolyzed in 6 N HCI, 
heated to 110·C under vacuum (Millipore Picotag Workstation), and dried 
using a Speed-Vac concentrator (Savant). Cysteic acid was added to the 
samples as an internal standard for retention time owing to its stability 
during hydrolysis. All samples were normalized against this standard. 
Amino acid content was analyzed on a Beckman Model 6300 amino acid 
analyzer equipped with a ninhydrin detector. Data were collected on a 
386AT computer using Chrom Perfect Data Acquisition system (Justice 
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Figure 2. ~r;~l1Smission electron micrographs of capsules harvested from 
pump. c.ontalrung PBS (a) or relaxin (b,c). a, Section of control capsule 
cont~lru~g fibro~last (fb) and macrophagelike cells (m). Collagen fibrils in 
longltudmal (solid arrow) and cross section (opell arrow) are abundant in the 
ex~racellular .space. Bar, l/lm. b, SectIOn of capsule from relaxin-treated 
alllm~1 showmg fibroblasts (fb) differentiated for secretion, similar to those 
seen ll1 control capsules .. Collagen fibrils appear less reguIarly packed than 
those .seen m control sectIOns. Bar, 1 /lm. c, Section of relaxin-treated capsule 
showmg extracellular accumulations of amorphous electron-dense material 
adjacent to collagen fibrils, suggestive of collagen degradation. Bar, l/lm. 
IlIs.et, collagen fibrils or fibril fragments (arrows) are present within accumu-
lations of the amorphous material. Bar, 1 /lm. 
Innovations, Inc). Data were analyzed on a Vax8600 using the Amino pro-
gram [21] . 
His~ology T he intact capsules and hemisections of the sponge were for-
malm-fixed, and stained with hematoxylin eosin, and Masson's trichrome to 
identify collagen. Scoring of capsule size involved blind determination of 
capsule waI l thickness and wall compactness as seen on histologic examina-
tion of capsule cross sections. The capsule wall, excluding fat and muscle that 
may have been simultaneously dissected, was measured for cross-sectional 
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Table I. Relaxin Decreases Hydroxyproline Content of Polyvinyl Alcohol Sponges· 
Hydroxyproline 
Content/Sponge Wet Weight Dry Weight 
Group Number (Ilg)b (mg)< (mg)< 
Experiment 1 
Control 5 469.7 ± 84.1 653.5 ± 76.8 57.9 ± 6.0 




5 449.0 ± 33.0 687.3 ± 86.5 58.2 ± 9.5 
5 369.4 ± 34.0J 646.7 ± 63.3 51.6 ± 1.7 
4 353.1 ± 41.0J 778.4 ± 24.9J 59.7 ± 8.7 
Control 5 434.9 ± 37.2 494.0 ± 49.3 45.2 ± 1.6 
Relaxin 5 ng/ml 
15 ng/ml 
30 ng/ml 
5 376.5 ± 25.9J 550.7 ± 76.4 44.9 ± 4.3 
5 333.4 ± 28.9' 499.6 ± 40.9 41.0 ± 3.0 
4 308.3 ± 40.8' 603.7 ± 39.0J 44.7 ± 2.4 
• Experiment 1 includes one disk sponge harvested from each of19 rats. Experiment 2 includes one ring sponge harvested from each of the same 19 rats. All values are means ± SO . 
• Total hydroxyproline content per sponge was determined following dehydration, as described in Materials alld Methods. 
, Sponges were harvested from rats and weighed before and after dehydration. Tissue wet and dry weights were calculated by subtracting original dry weights of the sponges from 
weights determined at harvest. 
i Significantly different from control (p < 0.05). 
'Significantly different from control (p < 0.01). 
thickness. Density of tissues comprising the wall, ascertained by the inten-
sity of trichrome staining, constituted "wall compactness." Five-step sec-
tions of three blocks per control and relaxin groups were analyzed. Slides 
were scored on a relative, semiquantitative scale of 0 to 4, with 0 equivalent 
to no response to pump implantation (no capsule formed) and 4 equal to the 
most vigorous resfonse observed in the study. 
Quantitation 0 cell infiltrates into the polyvinyl alcohol sponges was 
done by examining hematoxylin-stained sections. A multiapplications sys-
tem for image analysis (RAS 3000, Amersham, IL) was used on approxi-
mately 30 randomly selected fields per slide. Nuclei of cells per field were 
counted under 400 power on a microscope. 
Statistical Analysis The data from the sponge study were analyzed by 
analysis of variance. When the overall F test showed a significant difference 
among groups, individual group means were compared to the mean of the 
control group using the Dunnett t test. Sample size was 4 to 5 sponges per 
group. 
Transmission Electron Microscopy Capsules and hemisections of the 
sponge were fixed in 1 % glutaraldehyde and 1.25% paraformaldehyde in 
0.1 M cacodylate buffer (Karnovsky's), post-fixed in 2% osmium in the same 
buffer, and en bloc stained overnight in uranyl acetate. Sixty- to ninety-nano-
meter sections were counter-stained with uranyl acetate and lead citrate and 
examined on a Phillips CM12 transmission electron microscope. 
RESULTS 
Capsule Formation Circulating relaxin levels, determined just 
prior to sacrifice, ranged from 577 to 882 pg/ml with a mean of 
729 ± 40 pg/ml in relaxin-treated animals and below detectable 
levels «20 pg/ml) in the control group. Upon retrieval of the 
pump, a discrete capsule representing a strong fibrotic response to 
foreign body implantation was observed surrounding the pump in 
control (PBS alone) animals. Histologic examination demonstrated 
that the capsules were comprised of dense collagen-containing con-
nective tissue, as determined by trichrome staining of sections (Fig 
lA) . Mononuclear cells were abundant throughout the sections. 
The capsules harvested from relaxin-loaded pumps were thinner, 
with fewer cells embedded in a collagenous matrix (Fig IB). Cap-
sule wall thickness and wall compactness were scored semiquantita-
tively on a scale of 1 to 4, by examination of tissue sections in 
blinded fashion, as described in Materials and Methods. Capsule wall 
thickness measurements in the 15 slides from three animals in the 
control group averaged a score of 3.7 ± 0.1 (mean ± SD), com-
pared with that from the group whose pumps were loaded with 
relaxin, which had a capsule response of2.3 ± 0.7. Compactness of 
capsules from control animals averaged 3.5 ± 0.2, whereas that of 
capsules from relaxin-treated animals was 2.6 ± 0.7. IFN-y, which 
had previously been tested in this model [12], was also assayed as a 
positive control and for comparison with relaxin. IFN-y was more 
potent than relaxin in inhibiting capsule formation, with a cap-
sule wall thickness score of 1.8 ± 0.3 and a compactness score of 
1.9 ± 0.3. 
The differences in capsule response in animals treated with re-
laxin or PBS were also noted at the ultrastructural level. Capsules 
from control animals were comprised of fibroblasts embedded 
within an extracellular matrix of densely packed parallel arrays of 
collagen bundles (Fig 2A) . Collagen fibrils, assessed either in cross-
section or longitudinal section, were of uniform diameter and dem-
onstrated many areas of parallel stacking with even spacing. Fibro-
blasts were abundant and displayed an actively secretory phenotype 
with a high density of endoplasmic reticulum and Golgi-apparatus 
organelles. Occasional macrophagelike cells were also observed. 
Capsules from relaxin-loaded pumps also contained numerous fi-
broblasts with a morphology similar to that seen in cells in control 
capsules. The deposition of collagen in the interstitium, however, 
differed in that fibrils were less abundant and less ordered than in 
control samples (Fig 2B). Parallel arrays of fibrils organized into 
bundles were less frequent than in control capsules. Fibril diameter 
size also frequently appeared smaller, although this was not quanti-
fied. Fields comprised of electron-dense pericellular material in 
which collagen fibrils were interspersed were observed in capsules 
from relaxin-treated animals and not from control animals (Fig 2C). 
Polyvinyl Alcohol Sponge Infiltration Serum relaxin levels 
assayed just prior to sacrifice averaged 0, 5, 15, and 30 ng/ml in the 
four groups of animals. Gross surface examination of sponges upon 
harvest revealed infiltration of interstices with fibrous connective 
tissue. Sponge wet weights, of either design at harvest, did not differ 
among control or treatment groups receiving 5 and 15 ng/ml re-
laxin (Table I). The sponges from the group receiving 30 ng/ml 
relaxin averaged a wet weight of 777.8 mg in the case of the disk 
sponges and 603.3 mg in the case of ring sponges; these weights 
were - 20% higher than those from the matched controls (p < 
0.05). Dry weights of the sponges did not differ significantly among 
groups (Table I). Analysis of the hydroxyproline content of both 
disk and ring sponges following acid hydrolysis showed a relaxin 
dose-dependent decrease in total hydroxyproline content per 
sponge (Table I). Hydroxyproline content of disk sponges from 
animals receiving 15 and 30 ng/ml relaxin differed significantly 
(p < 0.05) from those harvested from control animals with de-
creases in total hydroxyproline content of as much as 25% in rats ' 
receiving the highest dose of relaxin. In the experiment using ring 
sponges, hydroxyproline content of sponges from animals receiving 
5 ng/ml relaxin was significantly different from control sponges 
(p < 0.05), whereas sponges from rats receiving 15 and 30 ng/ml 
relaxin had total decreases in hydroxyproline content of 23% and 
29% (p < 0.01). Because the wet weights of both disk and ring 
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Figure 3. Relaxin dose-dependent decrease in hydroxyproline content/~et 
weight of tissue in disk (A) and ring (B) sponges. Average hydroxyprolme 
• content per treatment group was standardized to the average wet weight of 
tissue per group. Bars, mean ± SO; .p < 0.0l. 
5 onges harvested from animals receiving 30 ng/ml relaxin were ~fferent from those of control animals, hydroxyproline content 
was standardized as a function of wet weight. This analysis demon-
strated that hydroxyproline content/wet tissue weight decreased 
from 0.072% in disk sponges from control rats to 0.045% III 
sponges from rats receiving 30 ng/ml relaxin, reflecting a decrease 
of 38% (p < 0.01) (Fig 3A). In the case of the ring sponges, hy-
droxyproline content decreased from 0.089% to 0.051 % of the wet 
weight of tissue in these rats, a decrease of 43% (p < 0.01) (Fig 3B) . 
Examination of hematoxylin-stained sections demonstrated vIg-
orous infiltration of all sponges by mononuclear cells. Quantitation 
of cell number within the sponges of both designs demonstrated no 
significant changes in the total num.ber of infiltrating cells per field, 
except at the highest relaxin dose (p = 0.05). H~re, there w~s ~ 23% 
decrease in total number of cells per field. Tnchrome stalllmg of 
sections of sponges from control animals demonstrated a marked 
accumulation of collagen within the interstices of the sponge ma-
trix, as well as along its exterior surface, as judged from the intensity 
of staining (Fig 4A). Overall, sponges from the group receiving the 
highest dose of relaxin showed a less intense trichrome staining than 
seen in control sponges (Fig 4B), demonstrating less collagen accu-
mulation. Margins of the disk still contained more collagenous ma-
terial than the interior of the sponge, but areas in which there was 
heavy deposition of collagen were smaller, with resultant broader 
areas showing lighter staining patterns. 
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DISCUSSION 
The ability to evaluate the potential of cytokines in modulating 
connective tissue rurnover in animal models is a powerful tool in 
understanding the biologic roles of these cytokines, as well as in 
assessing their possible utility in the treatment of human disease. 
Several cytokines, including platelet-derived growth factor [3], fi-
broblast growth factor [22], transforming growth factor (TGF)-P 
[1- 3], and insulinlike growth factor [23]' have demonstrated potent 
effects in accelerating or altering the course of wound healing in 
animals. The results of these animal studies augment and comple-
ment data accumulated on cytokine effects on cellular phenotype as 
evaluated in isolated cell systems ill vitro [5,6,24] . W e have previ-
ously shown that relaxin can cause a decrease in collagen expression 
in vitro in human skin fibroblasts. In the present study, we extended 
our observations to include the ability of relaxin to decrease active 
collagen accumulation by fibroblasts in vivo in two models of fibro-
sis. Capsule formation around osmotic pumps was initially selected 
as a model because IFN-y, another cytokine with collagen-reducing 
potential in lIitro, had previously been evaluated in this model [12]. 
Also, ultrastructural analysis of cell morphology and patterns of 
collagen deposition in the capsules is facilitated because the struc-
ture of the capsule is generally uniform throughout and therefore 
lends itself to analysis of very small fields. An assessment of relaxin's 
effect in the sponge model was then performed because quantitation 
of collagen accumulation, i.e., hydroxyproline content, was facili-
tated by using each sponge as a discrete denominator for analysis. 
This model was therefore selected for evaluation of a rel axin dose-
dependent effect on collagen accumulation. Because of the gradient 
nature of collagenous and cellu lar accumulation within the sponges, 
however, ultrastructural determinations were relative to location 
within the sponges and comparisons between groups were difficult. 
Therefore, the two models were complementary in the analysis of 
relaxin's effect on fibrosis. 
Our results show that relaxin causes a marked decrease in colla-
gen synthesis ill lIillo under conditions where rapid connective tissue 
accumulation is occurring. The readily harvested sponges demon-
strate that relaxin causes a dose-dependent decrease in collagen ac-
A 
B 
Figure 4. Histologic sections of sponges from rats receiving diluent alone 
(A) or relaxin (30 ng/ml) (B) . Sections were fix ed, sectioned, and stained 
with hematoxylin and Masson's trichrome. Hematoxylin-stained nuclei 
represent cellula.r infiltration. Collagenous connective tissue (arrow) stains 
blue with Masson's trichrome. Bar, 1 mm. 
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cumulation in this model; hydroxyproline content per sponge de-
creased by 25% to 29% at the highest relaxin dose (30 ng/ml). 
Although the ring design was used to provide a central core into 
which a concentration of tissue ingrowth could occur, there were 
no real differences in hydroxyproline accumulation between sponge 
designs. Both designs showed a significant dose-dependent decrease 
in collagen accumulation with increasing relaxin dose. Although 
quantitation of collagen content of the capsules proved to be diffi-
cult because of adhesion and consequent requisite excision of 
surrounding tissue from the capsule during harvest, we suggest 
from evaluation of histologic and ultrastructural sections that the 
amount of total collagen accumulated in the capsules from relaxin-
treated arumals is decreased compared to that from control animals. 
The decrease in relaxin-treated capsule thickness and compactness 
and the ultrastructural picture of an overall decrease in interstitial 
collage fibril density probably contribute to an overall decrease in 
collagen accumulation following relaxin treatment. It should be 
noted, however, that because the capsule surrounds the source of 
relaxin, i.e., the pump, the actual concentration of relaxin in that 
area is probably higher than serum levels. 
Tissue wet weights were increased in sponges from animals re-
ceiving the highest dose of relaxin compared with controls. Because 
dry weights did not change, we assume that this increase is indica-
tive of higher water content. If hydroxyproline accumulation is 
expressed as a function of wet weight, relaxin's effect is even more 
marked because collagen accumulation decreased as water content 
increased. Although we have no evidence for the basis of these 
changes, they suggest replacement of collagen by water-retentive 
matrix elements, perhaps glycosaminoglycans. 
The decrease in cell accumulation within the sponge and the 
relative scarcity of cells within sections of the capsule suggest that 
relaxin may also affect the rate of infiltration by cells into growing 
tissue or their proliferative capacity. Results of an incisional wound-
healing model in the rat have suggested that increases in the number 
of cells within cytokine-accelerated healing wounds, rather than an 
increase in the proportion of cells synthesizing collagen, is critical to 
increasing net collagen deposition [1]. In that model, then, chemo-
taxis and proliferation rather than activation of all cells into a colla-
gen synthetic phenotype are important to renewing tissue. In our 
models, it is possible that a decrease in chemotaxis or proliferation 
may be contributing to the inhibition in collagen accumulation 
caused by relaxin. However, because we also observe decreases in 
collagen accumulation at doses where significant decreases in cell 
number are not apparent, it is likely that both a decrease in collagen 
synthesis on a per cell basis, as well as a decrease in cell infiltration/ 
proliferation, contribute to the decreased collagen accumulation in 
relaxin-treated animals. 
Consistent with the finding that relaxin decreases collagen accu-
mulation in vivo under conditions of rapid collagen synthesis, studies 
il1 vitro have shown that relaxin's ability to down-modulate collagen 
expression by normal dermal fibroblasts is amplified when collagen 
synthetic rates are high, such as following stimulation of cells with 
TGF-p or interleukin-lp in the presence of indomethacin [7]. The 
cytokines relevant in initiating the cellular infiltration, prolifera-
tion, and resultant collagen deposition in our in vivo models of 
fibrosis are unknown. However, there is evidence from localization 
studies of healing wounds or fibrotic processes that TGF-p [3], 
transforming growth factor-a [24], and tumor necrosis factor-a 
[25] are candidate cytokines. These growth factors individually or in 
combination may be stimulating collagen accumulation in our 
models of fibrosis. How relaxin interferes with cytokine-stimulated 
collagen accumulation is of great interest. We know froln the 
present and previous work that relaxin can 1) inhibit the collagen-
stimulatory effects of two unrelated cytokines, TGF-p and interleu-
kin-lp, on fibroblasts il1 vitro [7]; 2) can also decrease the high 
constitutive collagen synthetic rates by scleroderma fibroblasts in 
vitro [26]; and 3) can interrupt collagen accumulation in these two 
models of fibrosis in vivo. Relaxin's effects are likely to occur at a 
point in the collagen-stimulatory signaling pathways common to all 
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of these processes; therefore, relaxin may be a valuable tool in defin-
ing what this common link(s) is . 
Because collagen accumulation is theoretically the sum of colla-
gen synthetic and degradative rates, relaxin may also accelerate the 
cells' ability to degrade collagen. Fibroblasts treated with relaxin ill 
vitro are induced to synthesize and secrete the metalloproteinase 
collagenase [7], which can initiate the degradation of interstitial 
collagens. Therefore, it is possible that increased degradative rates 
caused by relaxin contribute to reduced extracellular matrix deposi-
tion as well. The ultrastructural picture of pericellular electron-
dense regions containing fragments of collagen fibrils is consistent 
with this interpretation, although the static nature of micrography 
precludes any definitive conclusion. The possibility that relaxin 
stimulates synthesis of other non-collagen products, such as glycos-
aminoglycans, that are viewed ultrastructurally as electron-dense 
material must also be considered. 
In summary, relaxin decreases collagen accumulation in two ro-
dent models of fibrosis, demonstrating that it can interfere with 
interstitial matrix formation under conditions of rapid collagen syn-
thesis. These findings demonstrate that relaxin may have a biologic 
role in modulating connective tissue integrity in tissues outside 
those of the reproductive system. It also suggests that relaxin may 
have potential utility in the treatment of pathologic conditions of 
fibrosis, such as is seen in scleroderma and in keloid formation. 
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ANNOUNCEMENT 
A symposium dedicated to the 65th birthday of Howard I. Maibach, San Francisco, and orga-
nized by the Departments of Dermatology, Universities of Basel and Zurich, Switzerland, on 
"Exogenous Dermatology-Advances in Skin-Related Toxicology, Pharmacology, Allergol-
ogy and Bioengineering" will be held on July 1, 1994, in Basel, Switzerland. 
For further information please contact Chr. Surber, Ph.D., Department of Dermatology, 
University of Basel, Peters graben 4, CH-4058 Basel, Switzerland. T el. 0041-61-2652525; Fax 
0041-61-2654200. 
